ScoreWhy is Pharmaids Pharmaceuticals Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -1.81% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.18
2
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 22-May-26 and has generated -1.23% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -57.97%, its profits have fallen by -34%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -57.97% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmaids Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Pharmaids Pharma
-34.33%
-1.16
49.89%
Sensex
-11.86%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
197.54%
EBIT Growth (5y)
1.86%
EBIT to Interest (avg)
-7.66
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.24
Tax Ratio
34.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-26.75%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
36
Price to Book Value
2.26
EV to EBIT
-12.10
EV to EBITDA
-14.72
EV to Capital Employed
1.84
EV to Sales
5.16
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-21.94%
ROE (Latest)
-29.75%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 8.13 times
PAT(Q)
Highest at Rs -1.05 cr.
EPS(Q)
Highest at Rs 0.63
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.13 cr
Loading Valuation Snapshot...
Here's what is working for Pharmaids Pharma
Profit After Tax (PAT) - Quarterly
Highest at Rs -1.05 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.63
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debtors Turnover Ratio- Half Yearly
Highest at 8.13 times
in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Pharmaids Pharma
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.13 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
